In the current study, we demonstrated that an EBV‐encoded miRNA, EBV‐miR‐BART18‐3p, significantly promotes tumor growth and facilitates de novo lipogenesis in CRC by regulating the SIRT1/HIF1α/LDHA/FASN axis. The gene discussed is FASN; the disease is neoplasm.